The A −844G Polymorphism in the PAI-1 Gene Is Associated With a Higher Risk of Venous Thrombosis in Factor V Leiden Carriers
- 1 May 2000
- journal article
- other
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 20 (5) , 1387-1391
- https://doi.org/10.1161/01.atv.20.5.1387
Abstract
—Identification of combined genetic factors in factor V Leiden carriers is important for a more accurate risk assessment for venous thrombosis (VT). Among these individuals, we evaluated the role of polymorphisms of the plasminogen activator inhibitor-1 (PAI-1) gene in the thrombophilic phenotype. A total of 382 factor V Leiden carriers were included in the study. This population was divided into 3 groups. Group 1 (n=168) included individuals with a personal history of VT; group 2 (n=140) included individuals without personal VT but with a familial history of VT; and group 3 (n=74) included individuals without VT and with a fortuitous discovery of the factor V Leiden mutation. We compared the genotype distribution of 2 polymorphisms, A −844G and −675 4G/5G, located in the promoter region of the PAI-1 gene among these 3 groups of individuals. The A −844G allele frequency differed significantly among the 3 groups (P=0.048), the A allele being more frequent in patients who suffered from VT (61%) than in subjects without VT (52%, P=0.015), whereas no difference was observed between the 2 groups of asymptomatic individuals. The prevalence of genotype AA carriers was higher in patients with VT (38%) than in asymptomatic individuals (21%, P=0.015), leading to an odds ratio of 1.74 (95% confidence interval, 1.3 to 3.8). Carrying the AA genotype conferred a risk of deep VT of 2.08 (95% confidence interval, 1.28 to 3.40), whereas it did not seem to significantly influence the risk of pulmonary embolism. Concerning the −675 4G/5G polymorphism, no significant difference was observed among the 3 groups, the 4G allele frequency being 0.54 (in group 1), 0.49 (in group 2), and 0.45 (in group 3). These data suggest a role for the −A844G PAI-1 gene polymorphism in the thrombophilic phenotype of factor V Leiden carriers.Keywords
This publication has 21 references indexed in Scilit:
- Detection of a new polymorphism in the PAI-1 gene located in the pro-peptide coding regionFibrinolysis and Proteolysis, 1999
- Additional genetic risk factors for venous thromboembolismin carriers of the factor V Leiden mutationBritish Journal of Haematology, 1998
- The 4G/5G Sequence Polymorphism in the Promoter of Plasminogen Activator Inhibitor-1 (PAI-1) Gene: Relationship to Plasma PAI-1 Level in Venous ThromboembolismThrombosis and Haemostasis, 1998
- A Common 4G Allele in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene as a Risk Factor for Pulmonary Embolism and Arterial Thrombosis in Hereditary Protein S DeficiencyThrombosis and Haemostasis, 1998
- The 4G/5G Polymorphism of PAI-1 Promoter Gene and the Risk of Myocardial Infarction: A Meta-analysisThrombosis and Haemostasis, 1998
- Factor V Leiden Mutation and the Risks for Thromboembolic Disease: A Clinical PerspectiveAnnals of Internal Medicine, 1997
- Testing Association between Candidate-Gene Markers and Phenotype in Related Individuals, by Use of Estimating EquationsAmerican Journal of Human Genetics, 1997
- A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSISThrombosis Research, 1996
- Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.Proceedings of the National Academy of Sciences, 1995
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986